Biotechnology

Dr. S. Narasimha Murthy


Dr. S. Narasimha Murthy is currently an Assistant Professor at the Department of Pharmaceutics, The University of Mississippi School of Pharmacy. Dr.Murthy obtained his Ph.D from the Bangalore University, Karnataka, India. He worked as a post doctoral research associate at Roswell Park Cancer Institute, Buffalo, NY during 2002-2005. Before joining the University of Mississippi in 2006, Dr.Murthy worked as a faculty at Ohio Northern University, Ada, OH.

Dr. Murthy’s research at the University of Mississippi focuses on developing Electrically Mediated Noninvasive Technologies for drug delivery, diagnosis and treatment of various diseases. He has developed electrically mediated technique to sample drugs from the skin as a tool to monitor the effectiveness of the treatment. He has also developed electrical techniques to deliver drugs rapidly across the nail plate to treat nail diseases such as onychomycosis. The OcuDrain-E technique developed by his group is a potential method of treating glaucoma patients who respond poorly to drugs. He discovered the technique of magnetophoresis, a magnetically mediated method to enhance the drug delivery across the skin. Dr. Murthy’s research programs are supported by NIH and Pharmaceutical companies. Dr. Murthy has about 50 research publications, two pending patents and over 40 conference presentations to his credit. Dr.Murthy’s research group consists of graduate students and post doctoral research associates. He has research collaborations with Pharmacy schools and research institutes in India. For more details on Dr.Murthy’s research visit http://www.pharmacy.olemiss.edu/pharmaceutics/murthy/

back to top

Dr. Ravi Kane

Dr. Ravi Kane is the P. K. Lashmet Professor of Chemical and Biological Engineering at RPI where he leads an interdisciplinary research team focusing at the interface of biotechnology and nanotechnology. His mission is the engineering of polyvalent therapeutic molecules and the molecular engineering of biosurfaces and nanostructures. His group is designing therapeutics for diseases such as anthrax and AIDS. He has also been at the forefront of nanobiotechnology where he has investigated the fundamentals of the interaction between proteins and nanostructures such as carbon nanotubes and applied his findings for developing nano-structured materials that recognize and inhibit target toxins. Dr. Kane received a B.S. in Chemical Engineering with distinction from Stanford University in 1993 and a Ph.D. in Chemical Engineering from MIT in 1998. After postdoctoral research in the Department of Chemistry and Chemical Biology at Harvard University, Dr. Kane joined Rensselaer Polytechnic Institute as an assistant professor in 2001. He was promoted to associate professor in 2006, to professor in 2007, and to the P.K. Lashmet Professor in 2008. In 2004, he was recognized by MIT’s Technology Review Magazine as one of the top 100 young innovators in the world. In 2008, he received a young investigator award from the AIChE Nanoscale Science and Engineering Forum, a NYSTAR faculty development award, and was selected as the Dr. G.P. Kane Visiting Professor in Chemical Engineering at the University Institute of Chemical Technology, Bombay, India. In 2009, he received a young investigator award from the ACS Biochemical Technology Division. Dr. Kane has numerous publications (~ 80) in leading journals (e.g. Nature Biotechnology, Nature Nanotechnology, and Proceedings of the National Academy of Sciences, USA). Please visit his website at RPI for further information: http://www.rpi.edu/~kaner/

back to top